Technology Review Mississippi
SEE OTHER BRANDS

Your science and technology news from Mississippi

Technology Review Mississippi: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Review Mississippi.

Press releases published on August 14, 2025

ARRAY Technologies Completes Acquisition of APA Solar

ARRAY Technologies Completes Acquisition of APA Solar

ALBUQUERQUE, N.M., Aug. 14, 2025 (GLOBE NEWSWIRE) -- ARRAY Technologies (NASDAQ: ARRY) (“ARRAY” or the “Company”), a leading global provider of solar tracking technology products, software, and services for utility-scale solar energy projects, today …

Plus Therapeutics Reports Second Quarter Financial Results and Recent Business Highlights

Plus Therapeutics Reports Second Quarter Financial Results and Recent Business Highlights

Announced CNSide® CSF assay platform launch timeline Initiated the REYOBIQ dose optimization trial for patients with leptomeningeal metastases HOUSTON, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), a …

Microchip Technology to Webcast Annual Meeting of Shareholders

Microchip Technology to Webcast Annual Meeting of Shareholders

CHANDLER, Ariz., Aug. 14, 2025 (GLOBE NEWSWIRE) -- (NASDAQ:MCHP) – Microchip Technology Incorporated, a leading provider of smart, connected, and secure embedded control solutions, today announced that it will webcast its Annual Meeting of Shareholders …

Updated time: HP Inc. to Announce Third Quarter Fiscal 2025 Earnings on Aug 27, 2025

Updated time: HP Inc. to Announce Third Quarter Fiscal 2025 Earnings on Aug 27, 2025

PALO ALTO, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- HP Inc. (NYSE: HPQ) will present a live audio webcast of a conference call to review financial results for the third fiscal quarter ended July 31, 2025 on Wednesday, Aug 27, 2025 at 4:30 p.m. ET / 1:30 p …

Duos Technologies Group Reports Second Quarter 2025 Results

Duos Technologies Group Reports Second Quarter 2025 Results

JACKSONVILLE, Fla., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Duos Technologies Group, Inc. (“Duos” or the “Company”) (Nasdaq: DUOT), a provider of adaptive, versatile and streamlined Edge Data Center (“EDC”) solutions and operational services for the deployment …

Shuttle Pharma Provides Second Quarter 2025 Corporate Update

Shuttle Pharma Provides Second Quarter 2025 Corporate Update

GAITHERSBURG, Md., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer …

Diginex Announces extension of Resulticks MOU

Diginex Announces extension of Resulticks MOU

LONDON, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Diginex Limited (“Diginex” or the “Company”) (NASDAQ: DGNX),  a leading provider of Sustainability RegTech solutions, today announced that, by mutual consent, the Company and Resulticks Global Companies Pte. …

Fortress Biotech Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

Fortress Biotech Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

Fortress subsidiary Checkpoint Therapeutics acquired by Sun Pharma; Fortress received ~$28 million at closing and is eligible to receive up to an additional $4.8 million under a contingent value right (CVR), plus a 2.5% royalty on future net sales of …

Bolt Biotherapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update

Bolt Biotherapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update

Next-generation claudin 18.2 ISAC BDC-4182 now in Phase 1 dose-escalation study Cash balance of $48.5 million as of June 30, 2025 anticipated to fund key milestones through mid-2026 REDWOOD CITY, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Bolt …

Pyxis Oncology Reports Second Quarter 2025 Financial Results and Provides Business Update

Pyxis Oncology Reports Second Quarter 2025 Financial Results and Provides Business Update

–  Phase 1 monotherapy expansion study of micvotabart pelidotin (MICVO) for recurrent and metastatic head and neck squamous cell carcinoma (R/M HNSCC) patients progressing well with preliminary data in second half of 2025 and first half of 2026 –  Phase 1/ …

CAMP4 Reports Second Quarter 2025 Financial Results and Corporate Highlights

CAMP4 Reports Second Quarter 2025 Financial Results and Corporate Highlights

Presented positive translational data from SYNGAP1-related disorders program showcasing efficacy in a humanized SYNGAP mouse model and increased protein in non-human primates at the 28th American Society of Gene and Cell Therapy (ASGCT) Annual Meeting …

Magnite to Participate in Upcoming Financial Conferences

Magnite to Participate in Upcoming Financial Conferences

NEW YORK, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Magnite (Nasdaq: MGNI), the largest independent sell-side advertising company, today announced that members of its executive team will participate and host investor meetings at the following financial conferences …

ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2025

ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2025

PORTLAND, Maine, Aug. 14, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the …

authID Reports Financial and Operating Results for the Second Quarter 2025; Delivers the Highest Revenue in the Company’s History

authID Reports Financial and Operating Results for the Second Quarter 2025; Delivers the Highest Revenue in the Company’s History

DENVER, Aug. 14, 2025 (GLOBE NEWSWIRE) -- authID® (Nasdaq: AUID) (“authID” or the “Company”), a leading provider of biometric identity verification and authentication solutions, today reported financial and operating results for the second quarter ended …

IO Biotech Reports Second Quarter 2025 Financial Results and Provides Business Highlights

IO Biotech Reports Second Quarter 2025 Financial Results and Provides Business Highlights

Announced clinical improvement in progression free survival observed in pivotal Phase 3 Trial of Cylembio® plus KEYTRUDA® (pembrolizumab) for the treatment of first-line advanced melanoma, but statistical significance narrowly missed; company plans to meet …

Banzai Reports Second Quarter 2025 Financial Results

Banzai Reports Second Quarter 2025 Financial Results

Revenue of $3.3 Million for Q2 2025, Representing 205% Growth from Q2 2024 Gross Profit of $2.7 Million for Q2 2025, Representing 267% Growth from Q2 2024; Gross Margin Expanded to 83.0% in Q2 2025 a 1390 BPS Increase Management to Host Second Quarter 2025 …

Intchains Group Limited Reports Second Quarter and First Half 2025 Financial Results

Intchains Group Limited Reports Second Quarter and First Half 2025 Financial Results

Reinforces its Leading ETH Treasury Position: Increased ETH holdings to 8,816 as of June 30, 2025, up 26% from March 31, 2025, and 55% from December 31, 2024 Updates on Its Long-Term Dollar-Cost Averaging ETH Treasury Strategy Designed to Boost Overall …

Innventure Reports Second Quarter 2025 Results

Innventure Reports Second Quarter 2025 Results

Accelsius significantly grew market presence with recent deployments at Global Switch, Compucenter and Equinix facilities AeroFlexx delivered a fourth consecutive quarter of revenue generation Refinity engaged an engineering, procurement and construction …

zSpace Reports Second Quarter 2025 Financial Results

zSpace Reports Second Quarter 2025 Financial Results

SAN JOSE, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- zSpace (NASDAQ: ZSPC) (“zSpace” or the “Company”), a leader in augmented and virtual reality solutions for education, is announcing its financial results for the three and six months ended June 30, 2025. …

Vaxart to Host Virtual Stockholder Fireside Chat on Wednesday, August 20 to Discuss Reverse Stock Split Proposal

Vaxart to Host Virtual Stockholder Fireside Chat on Wednesday, August 20 to Discuss Reverse Stock Split Proposal

- ISS and Glass Lewis, leading independent proxy advisory firms, support reverse stock split proposal - - Webcast to begin at 4:30 p.m. ET / 1:30 p.m. PT - SOUTH SAN FRANCISCO, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT), a …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions